Susquehanna International Group, LLP Aptorum Group LTD Transaction History

Susquehanna International Group, LLP

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 14, 2023	SELL	$0.42 - $11.7 $28,595 - $796,582	-68,084 Reduced 75.24%	22,410 $12,000
Q3 2022 Nov 14, 2022	BUY	$1.14 - $12.9 $82,529 - $933,882	72,394 Added 399.97%	90,494 $104,000
Q2 2022 Aug 15, 2022	BUY	$0.95 - $1.67 $17,195 - $30,227	18,100 New	18,100 $25,000
Q1 2022 May 16, 2022	SELL	$1.22 - $2.28 $132,945 - $248,456	-108,972 Closed	0 $0
Q4 2021 Feb 14, 2022	BUY	$1.5 - $2.64 $76,494 - $134,629	50,996 Added 87.96%	108,972 $163,000
Q3 2021 Nov 15, 2021	BUY	$2.39 - $3.22 $138,562 - $186,682	57,976 New	57,976 $148,000

Ticker APM
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 13,265,500
Market Cap $28.1M
Description
Aptorum Group Limited, a biopharmaceutical company, engages in the discovery, development, and commercialization of therapeutic products for the treatment of infectious diseases and cancer. The company operates in the Therapeutics and Non-Therapeutics segments. Its pipeline products include SACT- 1 for neuroblastoma and other cancer types; SACT-...

Get notified when there are updates to the investment portfolio of Susquehanna International Group, LLP, based on Form 13F filings with the SEC.

Stay updated on Susquehanna International Group, LLP with notifications on news.